VANGUARD GROUP INC

Holdings History for Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

Symbol: ANVS on NYSE
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$3,194,275	923,201	+185,198	+25%	$3.46	Q4 2025
30 Sep 2025	0%	+0%	$1,527,667	738,003	+41,239	+5.9%	$2.07	Q3 2025
30 Jun 2025	0%	+0%	$1,511,978	696,764	+48,844	+7.5%	$2.17	Q2 2025
31 Mar 2025	0%	+0%	$971,881	647,920	+181,643		$1.50	Q1 2025
31 Dec 2024	0%	+0%	$2,345,373	466,277	+86,022	+23%	$5.03	Q4 2024
30 Sep 2024	0%	+0%	$3,064,855	380,255	+18,901	+5.2%	$8.06	Q3 2024
30 Jun 2024	0%	0%	$2,081,399	361,354	+3,412	+0.95%	$5.76	Q2 2024
31 Mar 2024	0%	+0%	$4,259,510	357,942	+20,588	+6.1%	$11.90	Q1 2024
31 Dec 2023	0%	+0%	$6,308,520	337,354	+78,824	+30%	$18.70	Q4 2023
30 Sep 2023	0%	+0%	$2,453,450	258,530	+6,500	+2.6%	$9.49	Q3 2023
30 Jun 2023	0%	+0%	$3,601,509	252,030	+9,459	+3.9%	$14.29	Q2 2023
31 Mar 2023	0%	0%	$3,738,019	242,571	0		$15.41	Q1 2023
31 Dec 2022	0%	0%	$3,257,728	242,571	+110	+0.05%	$13.43	Q4 2022
30 Sep 2022	0%	0%	$3,321,000	242,461	0		$13.70	Q3 2022
30 Jun 2022	0%	0%	$2,750,000	242,461	0		$11.34	Q2 2022
31 Mar 2022	0%	+0%	$3,237,000	242,461	+13,306	+5.8%	$13.35	Q1 2022
31 Dec 2021	0%	0%	$4,029,000	229,155	-329	-0.14%	$17.58	Q4 2021
30 Sep 2021	0%	0%	$7,285,000	229,484	+31	+0.01%	$31.75	Q3 2021
30 Jun 2021	0%	+0%	$19,637,000	229,453	+82,478	+56%	$85.58	Q2 2021
31 Mar 2021	0%	+0%	$4,101,000	146,975	+146,975	NEW	$27.90	Q1 2021
31 Mar 2021		0%	$1,000	26	0		$38.46 ^*	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.